Reactive Drug Metabolites
John Wiley & Sons, Sep 6, 2012 - Medical - 402 pages
Closing a gap in the scientifi c literature, this first comprehensive introduction to the topic is based on current best practice in one of the largest
pharmaceutical companies worldwide. The first chapters trace the development of our understanding of drug metabolite toxicity, covering basic concepts and techniques in the process, while the second part details chemical toxicophores that are prone to reactive metabolite formation. This section also reviews the various drug-metabolizing enzymes that can participate in catalyzing reactive metabolite formation, including a discussion of the structure-toxicity relationships for drugs. Two chapters are dedicated to the currently hot topics of herbal constituents and IADRs.
The next part covers current strategies and approaches to evaluate the reactive metabolite potential of new drug candidates, both by predictive
and by bioanalytical methods. There then follows an in-depth analysis of the toxicological potential of the top 200 prescription drugs, illustrating
the power and the limits of the toxicophore concept, backed by numerous case studies. Finally, a risk-benefi t approach to managing the toxicity risk of reactive metabolite-prone drugs is presented.
Since the authors carefully develop the knowledge needed, from fundamental considerations to current industry standards, no degree in pharmacology is required to read this book, making it perfect for medicinal chemists without in-depth pharmacology training.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Most Prescribed Drugs
Mediated Toxicity 1 8 Formation ofReactive Metabolites AmountFormed
Black Box Warnings
StructuralAlert andReactive Metabolite Analysis for the Top 200Drugsin theUSMarket by Prescription
Mitigating Toxicity RiskswithAffinity Labeling
1Introduction 10 2Identification Design of Structural Alerts and Avoiding them in Drug
Role ofReactive Metabolites in Genotoxicity
Other editions - View all
acetaminophen acyl glucuronides adducts agents aldehyde alkylation alkynes amines aniline anthracycline antibiotics antibodies antitumor aromatic Artemisinin benoxaprofen bioactivation pathway Biochemical Pharmacology Biochemistry Biological bioreductive carbamate Carcinogenesis carcinogenic cells Chemical Research Clinical Pharmacology compounds conjugate covalent binding crosslinking cytochrome P450 cytotoxicity derivatives detection DNA adducts dose Drug Metabolism druginduced electrophilic enediyne enzyme epoxide Experimental Therapeutics Figure formed furan genotoxicity glucuronidation glutathione Guengerich halothane heme hepatic hepatocytes hepatotoxicity heteroaromatic heterocyclic human hydralazine hydroxylation identification iminium inactivationof incubation inhibition inhibitors interactions inthe irreversible isoniazid Journal of Pharmacology Kalgutkar liver microsomes mechanism Mechanismbased inactivation Medicinal Chemistry Metabolic activation Metabolism and Disposition metabolites mitomycin moiety Molecular mutagenic NAPQI nitrogen NSAIDs nucleophilic ofthe P450 enzymes Pharmacokinetics Pharmacology Pharmacology and Experimental potential proteins quinone methide radical rats reaction reactive intermediate reactive metabolite formation Research in Toxicology ring rofecoxib species studies substituents substrate sulfonamide suprofen thiol thiophene tienilic acid tothe toxicity troglitazone undergo valdecoxib vitro vivo